The American Kennel Club and Pfizer are going to partner on dog research.
How perfect is that?
The AKC makes diseased and defective dogs, and Pfizer makes medications to treat the same.
And of course, the AKC also sells pet insurance so that pet owners can afford to buy all those Pfizer medicines that are needed to treat the diseased and defective dogs that are being cranked out by AKC breeders.
As the press release notes:
The partnership might also help Pfizer curry favor with veterinarians and win loyalty to brands such as its Vanguard vaccine against distemper and other viruses.
Medicines for pets and livestock have become a hot area for huge pharmaceutical companies trying to diversify in an effort to combat the potential loss of billions in annual revenue as their blockbuster drugs get cheaper generic competition.
Treatments for pets are particularly appealing because they rarely face generic competition and prices are not negotiated down by insurance companies and government health programs, as with drugs for people. In addition, global sales of animal drugs and vaccines have been rising at a steady rate of 5 percent a year, partly fueled by bigger livestock herds as the growing middle class in emerging markets eats more meat.
.
No comments:
Post a Comment